Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CCRT followed by VIPD in Nasal NK/T-cell Lymphoma
NCT00418535Phase 2Completed
- Sponsor
- Samsung Medical Center
- Start
- Apr 2006
- Primary completion
- Mar 2009
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of etoposide, ifosfamide, cisplatin, dexamethasone in Extranodal NK/T-cell lymphoma nasal type (ENKTCL-NT), sponsored by Samsung Medical Center. Started Apr 2006; status: completed.
02
Drugs
etoposideifosfamidecisplatindexamethasone
03
Conditions
Extranodal NK/T-cell lymphoma nasal type (ENKTCL-NT)
Beyond the preview
Go deeper on NCT00418535.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00418535.